MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board CAPE TOWN, South Africa, July 19, 2023 (GLOBE NEWSWIRE) -- via IBN -- Institute of Biomedical Research Corp. (OTC PINK: MRES) ("Institute of Biomedical Research" or the "Company"), a nutraceutical...

MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits CAPE TOWN, South Africa, July 17, 2023 (GLOBE NEWSWIRE) -- via IBN -- Institute of Biomedical Research Corp. (OTC PINK: MRES) (“Institute of Biomedical Research” or the "Company"), a nutraceutical...

Institute of Biomedical Research Corp Announces Purchase of Biomedical and Nutraceutical Assets SEATTLE, WA, July 22, 2022 (GLOBE NEWSWIRE) -- Institute of Biomedical Research Corp. (OTC Pink: MRES), a diversified biomedical company, announces the purchase of biomedical and nutraceutical...